We are reaching out to patients who were hospitalized at UNC and are also eligible for cardiac rehabilitation. We want to learn more about what the barriers are to attending cardiac rehabilitation. Did you not know it existed? Did the time commitment seem too much? What other questions did you have?

Study the effects of Ponsegromab a new drug in patients with heart failure

Looking at the effect of the study drug in addition to cholesterol medicine vs. cholesterol medicine alone on patients who are hospitalized with a heart attack.

The purpose of this study is to evaluate the safety and effectiveness of the ACURATE TAVR system in patient with severe aortic valve stenosis who are identified as an appropriate candidate for the TAVR procedure.

This study is to see if a special type of ultrasound can detect fluid in lungs, with the ultimate goal that maybe this ultrasound technique can be used in the future to help patients with heart failure.

To evaluate data from patients treated with the Arctic Cryoablation system.

The primary study objective is to compare the clinical outcomes of patients treated with the FlowTriever System versus Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute intermediate-high-risk pulmonary embolism (PE).

Comparing effects of a drug called ziltivekimab versus a placebo on heart disease and chronic kidney disease.

The objectives of this pivotal clinical trial are to evaluate the safety and effectiveness of the PASCAL System for transcatheter tricuspid valve repair with OMT (optimal medical therapy) compared to OMT alone in the treatment of patients with symptomatic severe tricuspid regurgitation.

The purpose of this registry is to observe outcomes of heart transplant recipients who are managed with HeartCare. This is done by collecting information about your heart transplant such as test results, biopsy results, and outcomes, storing that information in a database, and using that information for research.